Pegsitacianine

N/A

Report date: 2023/01/05 09:30:11
NME

Base Information

Drug NamePegsitacianine
Drug Alias NameONM-100ONM-100 DS
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo)
Mechanisms of ActionDiagnostic imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical CenterOnconano Medicine Inc
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[10] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A